| ETAGX | PMBJX | ETAGX / PMBJX | |
| Total Expense Ratio | 1.41 | 0.78 | 181% |
| Annual Report Gross Expense Ratio | 1.41 | 0.78 | 181% |
| Fund Existence | 16 years | 25 years | - |
| Gain YTD | 18.855 | -0.564 | -3,346% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.9B | 30.8B | 9% |
| Annual Yield % from dividends | 0.00 | 0.06 | - |
| Returns for 1 year | 16.43 | -6.46 | -254% |
| Returns for 3 years | 31.79 | 32.39 | 98% |
| Returns for 5 years | 0.12 | 25.52 | 0% |
| Returns for 10 years | 125.35 | 89.12 | 141% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GDMN | 80.97 | 0.86 | +1.07% |
| WisdomTree Efcnt Gld Pls Gld Ms Stgy ETF | |||
| SIXP | 30.84 | 0.08 | +0.26% |
| AllianzIM US Lrg Cp 6M Bfr10 Mar/Sep ETF | |||
| ILTB | 50.15 | -0.07 | -0.14% |
| iShares Core 10+ Year USD Bond ETF | |||
| EFAA | 52.17 | -0.11 | -0.21% |
| Invesco MSCI EAFE Income Advantage ETF | |||
| IBB | 165.22 | -1.25 | -0.75% |
| iShares Biotechnology ETF | |||